Cargando…
Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates
Cervical cancer has recently become one of the most prevalent cancers among women throughout the world. Traditional cancer therapies generate side effects due to off-target toxicity. Thus, novel cancer medications coupled with suitable drug delivery systems are required to improve cancer therapies....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600185/ https://www.ncbi.nlm.nih.gov/pubmed/37880286 http://dx.doi.org/10.1038/s41598-023-45537-x |